All filters
Slidesets
The future of patient monitoring- Hans-Jürgen Stellbrink, MD
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Underdiagnosis and suboptimal care of diabetes mellitus in a French HIV-infected cohort in 2016 - Dr. A. Sautereau
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Case discussion: How do drugs/patients impact need and type of monitoring- Marta Boffito, MD, PhD, FRCP
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
The rate of HIV transmission within serodiscordant heterosexual couples- Dr. A. Tudor
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
The role of social media in optimizing medical care- Matthew Hodson
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Developing a ChemSex Care Plan- Dr. D. Stuart
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Value-based healthcare in HIV management – The Economists Perspective- Phil McEwan
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Value-based healthcare in HIV management – The Clinicians’ Perspective- Jean-Jacques Parienti
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
Value-based healthcare in HIV management – The Patienst’ Perspective - real life - Kees Brinkman, MD, PhD
Presented at:
European Workshop on Healthy Living with HIV 2017
Slidesets
ADA-formation and its effect on Mab PK | Maria-Jesus Garrido, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Clinical case discussions | Howard Gurney, MBBS, FRACP
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Evaluation of a physiological based pharmacokinetic model to evaluate the influence of covariates on sunitinib exposure
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Optimal design – potential application in oncology drug development and clinical practice | Andrew Hooker, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Assessment of the release of daunorubicin from liposomes after administration of daunoXome® using population pharmacokinetics
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Model-based TDM for oncology drugs | Ron Keizer, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Physiologically based PK model vs. Population PK approach during drug development | Italo Poggesi, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Opening Lecture: Inter- and intravariability in PK | Mark Ratain, MD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Trough dabrafenib plasma concentrations can predict occurrence of adverse effects requiring dose reduction in metastatic melanoma
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Clinical case discussions | Nielka van Erp, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
Modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017
Slidesets
PK and PKPD considerations for dose selection in the development of pembrolizumab | Dinesh de Alwis, PhD
Presented at:
International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2017